Search results
Jury awards Beaverton woman $260M in cancer lawsuit against Johnson & Johnson
KGW NewsChannel 8 Portland· 5 days agoKyung Lee was diagnosed with incurable mesothelioma last year. A Portland jury held Johnson & ...
Weik Capital Management Sells 1,567 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 14 hours agoWeik Capital Management decreased its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.2% during the 4th quarter, according to the company in its ...
Woman awarded $260M from Johnson & Johnson following cancer diagnosis
KALB Alexandria· 2 days agoA woman in Oregon was recently awarded $260 million in a lawsuit against pharmaceutical giant ...
Johnson & Johnson (NYSE:JNJ) is Westwood Holdings Group Inc.’s 7th Largest Position
ETF DAILY NEWS· 15 hours agoWestwood Holdings Group Inc. lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.8% in the fourth quarter, according to the ...
Is Johnson & Johnson A Good Quality Stock to Buy Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled the list of the 13 Best Quality Stocks to Buy Now according to the hedge funds...
Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the...
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Given the large stake in the stock by institutions,Johnson & Johnson's stock price...
Is Johnson & Johnson (NYSE:JNJ) the Best Mega-Cap Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since ...
Johnson & Johnson must pay $260M in latest talc trial, Oregon jury says - BusinessWorld Online
BusinessWorld· 6 days agoJOHNSON & JOHNSON (J&J) must pay $260 million to an Oregon woman who said she got mesothelioma, a...
Johnson & Johnson hit with hefty verdict in baby powder case - The Boston Globe
The Boston Globe· 5 days agoJohnson & Johnson was ordered by an Oregon jury to pay $260 million to a woman who blamed her cancer...
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Zacks via Yahoo Finance· 4 days agoThe latest trading session saw Johnson & Johnson (JNJ) ending at $145.97, denoting a -1.24%...